You are here

  • Home
  • Archive
  • Volume 16, Issue 2
  • A three-step critical pathway for community-acquired pneumonia reduces duration of hospital stay and intravenous antibiotic use by 2 days

Article Text

Article menu
PDF
Adult nursing
Randomised controlled trial
A three-step critical pathway for community-acquired pneumonia reduces duration of hospital stay and intravenous antibiotic use by 2 days
  1. Paula Peyrani
  1. Division of Infectious Diseases, University of Louisville, Louisville, Kentucky, USA
  1. Correspondence to: Dr Paula Peyrani
    Division of Infectious Diseases, University of Louisville, 501 E Broadway, MedCenter One, Suite 120, Louisville, KY 40202, USA; p0peyr01{at}louisville.edu

http://dx.doi.org/10.1136/eb-2012-101000

Statistics from Altmetric.com

Commentary on: Carratalà J, Garcia-Vidal C, Ortega L, et al . Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial: a 3-step critical pathway for CAP. Arch Intern Med 2012;172:922–8.OpenUrlPubMedWeb of Science

Implications for practice and research

  • Although early switch therapy and hospital discharge are well-recognised processes, current practices show that these practices are not well established worldwide.

  • Pathways are useful tools to remind treating physicians about criteria for early switch and discharge.

  • A behavioural change may be necessary in order to decrease the gap between national recommendations and current management of hospitalised patients with community-acquired pneumonia.

Context

Community-acquired pneumonia (CAP) remains within the 10 …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information:

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions